FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Sunday

 

Health Insurance Status Affects Medication Use in MS































Image Source: THECENTURYFOUNDATION

Rising costs and insurance coverage of disease-modifying drugs (DMDs) for multiple sclerosis adversely impact access to treatment, according to results from a large survey.

Notably, nearly 25% of respondents taking DMDs use free or discounted drug programs to pay for their treatment.

In order to evaluate the impact of health insurance coverage on DMD use, Guoqiao Wang, PhD, of the University of Alabama Birmingham, and colleagues surveyed participants of the North American Research Committee on MS registry in 2014. Ultimately, 6662 respondents were included in the analysis.

Over 98% of respondents reported having health insurance, however just over 22% reported having a negative insurance change compared to the year prior. Notably, respondents who had private insurance were more likely to report a negative change in insurance. Just over 6% of respondents who were not taking DMDs cited financial/insurance concerns as the sole reason. Among respondents who obtained DMDs through insurance, 3.3% experienced initial insurance denial of DMD use, 2.3% experienced denial of DMD switches, and 1.6% had to skip to split doses because of copay increase. Among respondents with relapsing-remitting multiple sclerosis, a negative insurance change increased the likelihood of not taking DMDs (odds ratio [OR] 1.50; 1.16–1.93), using free or discount drug programs to obtain DMDs (OR 1.89; 1.40–2.57), and encountering insurance challenges (OR 2.48; 1.64–3.76).

The researchers noted that economic analysis that does not account for the use of free or discount drug programs – which are substantial among patients with multiple sclerosis – may contribute to inaccurate results.

Story Source: The above story is based on materials provided by NEUROLOGYADVISOR
Note: Materials may be edited for content and length


Go to Newer News Go to Older News